Efficacy of the All-in-One Therapeutic Strategy for Severe Traumatic Brain Injury: Preliminary Outcome and Limitation

por Park, Young-Soo, Kogeichi, Yohei, Shida, Yoichi, Nakase, Hiroyuki
Publicado 2018

Therapeutic Anti-KIR Antibody of 1–7F9 Attenuates the Antitumor Effects of Expanded and Activated Human Primary Natural Killer Cells on In Vitro Glioblastoma-like Cells and Orthoto...

por Maeoka, Ryosuke, Nakazawa, Tsutomu, Matsuda, Ryosuke, Morimoto, Takayuki, Shida, Yoichi, Yamada, Shuichi, Nishimura, Fumihiko, Nakamura, Mitsutoshi, Nakagawa, Ichiro, Park, Young-Soo, Tsujimura, Takahiro, Nakase, Hiroyuki
Publicado 2023

Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro

por Tanaka, Yoshitaka, Nakazawa, Tsutomu, Nakamura, Mitsutoshi, Nishimura, Fumihiko, Matsuda, Ryosuke, Omoto, Koji, Shida, Yoichi, Murakami, Toshiharu, Nakagawa, Ichiro, Motoyama, Yasushi, Morita, Hiromichi, Tsujimura, Takahiro, Nakase, Hiroyuki
Publicado 2019

Ex Vivo Expanded and Activated Natural Killer Cells Prolong the Overall Survival of Mice with Glioblastoma-like Cell-Derived Tumors

por Shida, Yoichi, Nakazawa, Tsutomu, Matsuda, Ryosuke, Morimoto, Takayuki, Nishimura, Fumihiko, Nakamura, Mitsutoshi, Maeoka, Ryosuke, Yamada, Shuichi, Nakagawa, Ichiro, Park, Young-Soo, Yasukawa, Motoaki, Tojo, Takashi, Tsujimura, Takahiro, Nakase, Hiroyuki
Publicado 2021